Last update:

Diseases, Conditions, Syndromes news

Diseases, Conditions, Syndromes

Rwanda will deploy Marburg vaccine under trial as death toll rises to 12

Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of an outbreak that has killed 12 people.

Diseases, Conditions, Syndromes

Mpox epidemic: from first cases to vaccinations

As the Democratic Republic of Congo launches a vaccination campaign amid a flare-up of the sometimes deadly illness mpox, AFP looks at how the virus developed.

Diseases, Conditions, Syndromes

Biomarker can help health care assess severity of COVID-19

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have ...

Diseases, Conditions, Syndromes

WHO approves first mpox diagnostic test

The UN health agency said on Friday that it had approved the use of the first diagnostic test for mpox, a key tool in countries battling outbreaks.

Diseases, Conditions, Syndromes

Understanding liver fibrosis: Insights from Alagille syndrome

What influences the extent of scar tissue, or fibrosis, that develops in the liver when people suffer from liver disease? While a small amount of fibrosis is a normal part of the healing process, excessive fibrosis can occur, ...

Diseases, Conditions, Syndromes

Ghana confirms first case mpox in 2024

Ghana has recorded its first confirmed case of mpox in 2024, health authorities said on Thursday, as the virus continues to spread in Africa.

Diseases, Conditions, Syndromes

How doxycycline for STI prevention affects the gut microbiome

Taking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted infections (STIs) in places where the strategy is being tried.

Medical research

Study identifies potential novel drug to treat tuberculosis

A new study published in Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant ...

Diseases, Conditions, Syndromes

Study addresses differentiating Meniere disease, vestibular migraine

The dissociation between pathological caloric testing and a normal video head impulse test can differentiate between Meniere disease (MD) and vestibular migraine (VM), according to a study published online Aug. 13 in Frontiers ...

Diseases, Conditions, Syndromes

More than 800 mpox deaths recorded across Africa

More than 800 people across Africa have died from mpox, the African Union's disease control center said Thursday, warning the epidemic "was not under control".

Diseases, Conditions, Syndromes

Lyme disease and ticks that carry it spread across the US

Lyme disease is one of the most prevalent insect-borne diseases in the country, with far more cases each year than other diseases carried by mosquitoes, fleas and ticks, such as the West Nile virus.

Diseases, Conditions, Syndromes

WHO launches plan to rein in 'alarming' dengue spread

The World Health Organization announced Thursday a global plan to battle dengue and other diseases carried by mosquitos as they spread faster and further amid climate change.

Genetics

Study weighs in on fears that COVID drug could spawn super virus

COVID-19 patients are often prescribed antiviral drugs that work by reducing the number of viral particles circulating in the body. One such drug, molnupiravir, tricks the virus into generating mutations, some of which are ...

Diseases, Conditions, Syndromes

Can you still get COVID tests for free?

COVID-19 hospitalizations and deaths are gradually increasing in the United States, as two new variants gain a foothold in the nation. And with that rise, more people are looking for COVID test kits.

Diseases, Conditions, Syndromes

CDC backs new COVID booster shots

Following an approval granted Monday by the U.S. Food and Drug Administration, the U.S. Centers for Disease Control and Prevention on Tuesday signed off on new COVID boosters for Americans.

Diseases, Conditions, Syndromes

Research team confirms immunity to COVID-19 reduces contagiousness

Nearly one in three people exposed to SARS-CoV2 is infected, and as many as two in five with the omicron variant. In the case of immunity—conferred by vaccination, infection or a combination of the two—this rate drops ...